Dotarizine

Overview

Dotarizine is a novel Piperazine (HY-B0912) derivative and antimigraine agent. Dotarizine exhibits Ca 2+ channel blocking properties. Dotarizine decreases the release of lactate dehydrogenase . Dotarizine shows 5-HT receptor blocking effect.

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Pain | Products > Disease Areas > Migraine | Products > Signaling Pathways > Others | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > 5-HT Receptor | Products > Signaling Pathways > Drug Derivative | Products > Signaling Pathways > Calcium Channel | Products > Signaling Pathways > Lactate Dehydrogenase

Product Information

• Catalog No.: HY-137162
• CAS No.: 84625-59-2
• Molecular Formula: C29H34N2O2
• Molecular Weight: 442.59
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source